More Invert Graphite Limited news
Invert Graphite LimitedASX: IVG

Last patient completes treatment in VLU Ph 2 Clinical Trial

Oct 3, 2018 at 11:02 PM EDT · Issued by Invert Graphite Limited

Filed with ASX · Oct 3, 2018 at 11:02 PM EDT · 1 page · English

On 6ix: 6ix.com/news/last-patient-completes-treatment-in-vlu-ph-2-clinical-trial

Invert Graphite Limited on 6ix

Story so far

  • Recruitment complete in VF00102 Phase 2 clinical trialJul 16, 2018
  • Screening to close as clinical trial nears completionJun 26, 2018
  • Clinical Trial UpdateJun 14, 2018

Earlier from Invert Graphite

  • Half Yearly Report and AccountsAug 23, 2018
  • Appendix 4C - June 2018 quarterJul 27, 2018
  • Recruitment complete in VF00102 Phase 2 clinical trialJul 15, 2018
  • Screening to close as clinical trial nears completionJun 25, 2018
  • Clinical Trial UpdateJun 14, 2018

Later from Invert Graphite

  • Factor Therapeutics Appoints Transaction AdvisorOct 15, 2018
  • Appendix 4C - September 2018 QuarterOct 19, 2018
  • Results of Phase 2 Clinical TrialNov 13, 2018
  • Management ChangeJan 25, 2019
  • Appendix 4C - December quarterJan 30, 2019
All Invert Graphite news releases↗

Follow Invert Graphite into a list and get an email when it puts out news.

Follow Invert Graphite
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer